Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Environmental Triggers for IBD.

O'Toole A, Korzenik J.

Curr Gastroenterol Rep. 2014 Jul;16(7):396.

PMID:
25048010
[PubMed - as supplied by publisher]
2.

Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome.

Meelu P, Marin R, Clish C, Zella G, Cox S, Yajnik V, Nguyen DD, Korzenik JR.

Inflamm Bowel Dis. 2014 Jul;20(7):1139-46. doi: 10.1097/MIB.0000000000000081.

PMID:
24892965
[PubMed - in process]
3.

SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease.

Fowler SA, Ananthakrishnan AN, Gardet A, Stevens CR, Korzenik JR, Sands BE, Daly MJ, Xavier RJ, Yajnik V.

J Crohns Colitis. 2014 Aug 1;8(8):845-51. doi: 10.1016/j.crohns.2014.01.003. Epub 2014 Jan 24.

PMID:
24461721
[PubMed - in process]
4.

Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts.

Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT.

BMJ. 2013 Nov 14;347:f6633. doi: 10.1136/bmj.f6633.

PMID:
24231178
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Marijuana use patterns among patients with inflammatory bowel disease.

Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J.

Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.

PMID:
24185313
[PubMed - in process]
6.

The accuracy of self-reported medical history: a preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases.

Kelstrup AM, Juillerat P, Korzenik J.

J Crohns Colitis. 2014 May 1;8(5):349-56. doi: 10.1016/j.crohns.2013.09.012. Epub 2013 Oct 31.

PMID:
24183653
[PubMed - in process]
7.

Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals.

Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V.

Inflamm Bowel Dis. 2013 Oct;19(11):2457-63. doi: 10.1097/MIB.0b013e3182a32a0d.

PMID:
23962896
[PubMed - indexed for MEDLINE]
8.

A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis.

Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT.

Gastroenterology. 2013 Nov;145(5):970-7. doi: 10.1053/j.gastro.2013.07.050. Epub 2013 Aug 2.

PMID:
23912083
[PubMed - indexed for MEDLINE]
9.

Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease.

Knutson CG, Mangerich A, Zeng Y, Raczynski AR, Liberman RG, Kang P, Ye W, Prestwich EG, Lu K, Wishnok JS, Korzenik JR, Wogan GN, Fox JG, Dedon PC, Tannenbaum SR.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2332-41. doi: 10.1073/pnas.1222669110. Epub 2013 Jun 10.

PMID:
23754421
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.

Oxford EC, Nguyen DD, Sauk J, Korzenik JR, Yajnik V, Friedman S, Ananthakrishnan AN.

Am J Gastroenterol. 2013 Jul;108(7):1123-9. doi: 10.1038/ajg.2013.20. Epub 2013 Feb 19.

PMID:
23419379
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C.

Genome Biol. 2012 Apr 16;13(9):R79. doi: 10.1186/gb-2012-13-9-r79.

PMID:
23013615
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease.

de Silva PS, Nguyen DD, Sauk J, Korzenik J, Yajnik V, Ananthakrishnan AN.

Aliment Pharmacol Ther. 2012 Sep;36(5):459-66. doi: 10.1111/j.1365-2036.2012.05214.x. Epub 2012 Jul 11.

PMID:
22784296
[PubMed - indexed for MEDLINE]
13.

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.

Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ.

PLoS One. 2012;7(6):e39242. doi: 10.1371/journal.pone.0039242. Epub 2012 Jun 29.

PMID:
22768065
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.

Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR.

Aliment Pharmacol Ther. 2012 Aug;36(3):239-47. doi: 10.1111/j.1365-2036.2012.05173.x. Epub 2012 Jun 5.

PMID:
22670722
[PubMed - indexed for MEDLINE]
15.

Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2013 Feb;19(2):309-15. doi: 10.1002/ibd.23026.

PMID:
22605668
[PubMed - indexed for MEDLINE]
16.

Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis.

Ananthakrishnan AN, Korzenik JR, Hur C.

Inflamm Bowel Dis. 2013 Jan;19(1):37-44. doi: 10.1002/ibd.22951.

PMID:
22416019
[PubMed - indexed for MEDLINE]
17.

Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives.

Ravikoff JE, Cole EB, Korzenik JR.

Inflamm Bowel Dis. 2012 Nov;18(11):2092-8. doi: 10.1002/ibd.22872. Epub 2012 Jan 12.

PMID:
22241674
[PubMed - indexed for MEDLINE]
18.

Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.

Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT.

Gastroenterology. 2012 Mar;142(3):482-9. doi: 10.1053/j.gastro.2011.11.040. Epub 2011 Dec 9.

PMID:
22155183
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.

Tinsley A, Macklin EA, Korzenik JR, Sands BE.

Aliment Pharmacol Ther. 2011 Dec;34(11-12):1328-36. doi: 10.1111/j.1365-2036.2011.04871.x. Epub 2011 Oct 17.

PMID:
21999576
[PubMed - indexed for MEDLINE]
20.

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.

Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR.

Aliment Pharmacol Ther. 2011 Dec;34(11-12):1318-27. doi: 10.1111/j.1365-2036.2011.04866.x. Epub 2011 Sep 29. Review.

PMID:
21957906
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk